Imágenes de interés
El virus SARS-COV-2 desencadena una respuesta inmunitaria antitumoral en un paciente con linfoma
SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient
T. Rudolphi-Solero
, M. Rashki, J. Fernández-Fernández, D. Rivas-Navas, C. Ramos-Font, A. Rodríguez-Fernández
Autor para correspondencia
Servicio de Medicina Nuclear, Hospital Universitario Virgen de las Nieves, Granada, España
Leído
407
Vecesse ha leído el artículo
33
Total PDF
374
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 14 | 0 | 14 |
| 2025 9 | 7 | 0 | 7 |
| 2025 8 | 10 | 0 | 10 |
| 2025 7 | 6 | 0 | 6 |
| 2025 6 | 10 | 0 | 10 |
| 2025 5 | 11 | 0 | 11 |
| 2025 4 | 7 | 0 | 7 |
| 2025 3 | 12 | 0 | 12 |
| 2025 2 | 8 | 0 | 8 |
| 2025 1 | 6 | 0 | 6 |
| 2024 12 | 12 | 0 | 12 |
| 2024 11 | 8 | 0 | 8 |
| 2024 10 | 3 | 0 | 3 |
| 2024 9 | 21 | 0 | 21 |
| 2024 8 | 15 | 0 | 15 |
| 2024 7 | 8 | 0 | 8 |
| 2024 6 | 7 | 0 | 7 |
| 2024 5 | 3 | 0 | 3 |
| 2024 4 | 8 | 0 | 8 |
| 2024 3 | 7 | 0 | 7 |
| 2024 2 | 23 | 0 | 23 |
| 2024 1 | 16 | 2 | 18 |
| 2023 12 | 41 | 0 | 41 |
| 2023 11 | 28 | 4 | 32 |
| 2023 10 | 26 | 0 | 26 |
| 2023 9 | 10 | 0 | 10 |
| 2023 8 | 10 | 0 | 10 |
| 2023 7 | 8 | 0 | 8 |
| 2023 6 | 2 | 0 | 2 |
| 2023 5 | 6 | 0 | 6 |
| 2023 4 | 4 | 2 | 6 |
| 2023 3 | 2 | 0 | 2 |
| 2023 2 | 4 | 3 | 7 |
| 2022 1 | 11 | 6 | 17 |
| 2022 12 | 0 | 2 | 2 |
| 2022 10 | 0 | 2 | 2 |
| 2022 9 | 0 | 2 | 2 |
| 2022 7 | 0 | 4 | 4 |
| 2022 2 | 0 | 2 | 2 |
| 2021 11 | 0 | 2 | 2 |
| 2021 6 | 0 | 2 | 2 |
Mostrar todo
